Verig Tablet 2.5 mg contains Vericiguat, a soluble guanylate cyclase (sGC) stimulator used to treat chronic heart failure with reduced ejection fraction (HFrEF). This lower starting dose is typically prescribed to initiate therapy safely, allowing the body to adjust while minimizing the risk of side effects. Vericiguat works by stimulating sGC, enhancing the nitric oxide–cGMP pathway, which relaxes blood vessels, reduces cardiac stress, and improves heart pumping efficiency.

Verig Tablet 2.5 mg is especially useful for patients who remain symptomatic despite receiving standard heart failure therapy, including ACE inhibitors, beta-blockers, and diuretics. It helps reduce hospitalizations related to worsening heart failure and supports better overall cardiovascular outcomes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Vericiguat 2.5 mg

Mechanism of Action

Vericiguat targets the nitric oxide–sGC–cGMP pathway in the cardiovascular system. By stimulating sGC, it increases cyclic GMP levels, which leads to:

• Relaxation of vascular smooth muscle

• Reduction of cardiac preload and afterload

• Improved cardiac efficiency and reduced ventricular stress

This mechanism directly addresses the pathophysiology of heart failure and enhances heart performance over time.

Indications

Verig Tablet 2.5 mg is indicated for:

• Chronic heart failure with reduced ejection fraction (HFrEF)

• Symptomatic patients not fully responding to standard therapy

• Reducing the risk of heart failure-related hospitalization and cardiovascular death

Dosage and Administration

• Typically initiated at 2.5 mg once daily as a starting dose

• Take orally at the same time each day

• Can be taken with or without food

• Dose may be gradually increased based on tolerance and blood pressure monitoring, usually up to 5 mg or higher per physician guidance

Careful monitoring is essential during dose titration to ensure safety and effectiveness.

Benefits of Verig Tablet

• Provides a safe initiation of Vericiguat therapy for heart failure patients

• Improves heart function and efficiency

• Reduces risk of hospitalization from worsening heart failure

• Supports better overall cardiovascular health

• Convenient once-daily dosing for consistent treatment

Possible Side Effects

Vericiguat is generally well-tolerated, but potential side effects may include:

• Low blood pressure (hypotension)

• Dizziness or lightheadedness

• Fatigue

• Headache

• Nausea

Patients should report severe hypotension, fainting, or allergic reactions to a healthcare professional immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use only under medical supervision

• Not recommended for patients with severe hypotension or cardiogenic shock

• Caution required in patients with impaired liver or kidney function

• Inform your doctor about all medications to prevent interactions

• Regular monitoring of blood pressure and heart function is advised

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Verig Tablet 2.5 mg is an effective and safe starting dose for managing chronic heart failure with reduced ejection fraction. With careful titration and monitoring, it supports improved heart performance, reduces hospitalizations, and enhances patient quality of life.